Raadr Inc (RDAR)

[Bubae]

If you are new to this ticker and looking for some due diligence rather than idle promotional chatter. Post linked below leads to links to the filings which shows the dilution that this company has queued up. These new Mexedia managers have added more than 3.6 billion shares to the float since they took control in October and we have a total OS count now of more than 6.7 billion. The Q1 financials has betrayed months of revenue promotion by revealing the nearly $2 million net loss for the quarter on 28 million in revenue. Now we have heavy promotion across social media to move this up since late April.

This Italy based company has rolled two of their subsidiaries into a company created for the purpose called Telvantis. If the reverse merger is consummated Mexedia will retain 75% ownership of Telvantis. After so many conversions and 8 months Mexedia still hasn't bought out the agreement which represents teh majority control of Raadr which begs the question of why not. This holding company now called Telvantis is a source of capital for Mexedia. Despite the benefit that the Mexedia shareholders get from this relationship the Mexedia stock is down 90% year over year and 78% since the beginning o f the year. These new Mexedia manager awarded themselves $1,050,000 in performance bonuses shortly after taking control dated November 15, 2024. Those agreements can either convert with the reg A offering or without at a 20% discount to market as rewritten in agreements filed March 03, 2025. So they raise capital using Raadr shares, pay the performance bonuses from Raadr shares, reverse split the bloated Raadr share structure for a proposed up-list attempt. No risk that I see for the Mexedia stock which trades on the Paris exchange yet they have sold it off. 🤔People here in the OTC are taking the bait in volume, some calling for $4 dollars a share on another board while the Mexedia stock trades at an equivalent of $1.42. Can't make this up.

Bubae
Re: Chartmaster post# 45643
Tuesday, June 03, 2025 1:04:46 PM
Post# 45648 of 45708 
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176270369

Nothing really mystical about it since you can not chart the dilution in the pipeline. Just the single piece of the dilution picture is the regulation A offering priced at $0.001. That is $1.5 million free trading shares since the offering was qualified in April. As of last weeks OS update the reg A and the more than $1.2 million of the subject convertible notes were fully intact. Those will probably be done post split.

Those promoting and converting control what is going on, not retail traders. IF they do the weekly update tomorrow morning before the open we may get some insight. Watch for either new additions or for the more than 600 million shares disparity between the unrestricted and that held at the DTC. The unrestricted grew with the OS additions especially the 375 million shares of the IBH capital note. Links to the filings are in the posts linked below. It would be a good time to skip the weekly update since showing that they are converting again blow up their current narrative.

MEXEDIA S.P.A
https://live.euronext.com/en/product/equities/IT0005450819-ALXP

Letter to Mexedia Shareholders October 16, 2024
https://live.euronext.com/en/product/equities/IT0005450819-ALXP#CompanyPressRelease-12536035

Mexedia S.p.A. SB strengthens global presence with the reverse takeover of U.S.-based Raadr. Key Players in the transaction: U.S. and Irish subsidiaries.

Mexedia S.p.A., a leading telecommunications and technology company listed on Euronext Growth in Paris, has completed the acquisition of its U.S. and Irish operational units by the U.S.-based Raadr Inc. (listed on OTC Markets). The transaction was completed via a reverse takeover involving Mexedia DAC and Mexedia Inc., both subsidiaries of Mexedia S.p.A.

The deal also includes plans for Raadr to uplist on NASDAQ, aiming to access greater liquidity and capital market opportunities.

Mexedia S.p.A. retains 75% control of Raadr through preferred equity with anti-dilution clauses. A fundraising round of between $10 million and $20 million for Raadr is set to commence immediately. Mexedia has the option to deconsolidate its stake by distributing Raadr shares to its own shareholders once the transaction is completed. The deal includes a safeguard clause that allows for cancellation of the transaction if a minimum of $1.5 million is not raised within six months from the start of fundraising.